# Fennec Pharmaceuticals Inc.: Form 8-K/A, filed Mar 6, 2024

- Company: [Fennec Pharmaceuticals Inc.](/companies/fenc.md) (CIK 1211583)
- Form: 8-K/A
- Filed: 2024-03-06
- Accepted by EDGAR: Mar 6, 2024, 16:07 ET
- Period: 2024-02-29
- Accession: 0001104659-24-031470
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1211583/000110465924031470/tm248156d1_8ka.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1211583/000110465924031470/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1211583/000110465924031470/tm248156d1_8ka.htm

Filed Mar 6, 2024.
Source: SEC EDGAR, the filing index for accession 0001104659-24-031470. Last ingested by Listed: Nov 2, 2026, 19:14 ET. No prices; not investment advice.